D
Repligen Corporation
RGEN
$155.70
-$4.41-2.75%
D
Sell
7/31/2024Downgrade
Repligen Corporation (RGEN) was downgraded to D from D+ on 7/31/2024 due to a large decline in the efficiency index, total return index and volatility index.
Repligen Corporation (RGEN) was downgraded to D from D+ on 7/31/2024 due to a large decline in the efficiency index, total return index and volatility index.
D
Sell
2/23/2024Downgrade
Repligen Corporation (RGEN) was downgraded to D+ from C- on 2/23/2024 due to a noticeable decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.32 to -$0.4566, net income declined 240.26% from $18.17M to -$25.49M, and operating cash flow declined 25.91% from $39.23M to $29.07M.
Repligen Corporation (RGEN) was downgraded to D+ from C- on 2/23/2024 due to a noticeable decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.32 to -$0.4566, net income declined 240.26% from $18.17M to -$25.49M, and operating cash flow declined 25.91% from $39.23M to $29.07M.
C
Hold
11/3/2023Downgrade
Repligen Corporation (RGEN) was downgraded to C- from C on 11/3/2023 due to a significant decline in the growth index, efficiency index and total return index. EBIT declined 239.14% from $21.19M to -$29.48M, total revenue declined 11.29% from $159.17M to $141.19M, and net income declined 9.43% from $20.06M to $18.17M.
Repligen Corporation (RGEN) was downgraded to C- from C on 11/3/2023 due to a significant decline in the growth index, efficiency index and total return index. EBIT declined 239.14% from $21.19M to -$29.48M, total revenue declined 11.29% from $159.17M to $141.19M, and net income declined 9.43% from $20.06M to $18.17M.
C
Hold
8/18/2023Upgraded
Repligen Corporation (RGEN) was upgraded to C from C- on 8/18/2023 due to an increase in the volatility index, total return index and valuation index.
Repligen Corporation (RGEN) was upgraded to C from C- on 8/18/2023 due to an increase in the volatility index, total return index and valuation index.
C
Hold
8/3/2023Downgrade
Repligen Corporation (RGEN) was downgraded to C- from C on 8/3/2023 due to a substantial decline in the growth index, valuation index and total return index. EBIT declined 34.78% from $32.49M to $21.19M, earnings per share declined from $0.51 to $0.35, and total revenue declined 12.86% from $182.66M to $159.17M.
Repligen Corporation (RGEN) was downgraded to C- from C on 8/3/2023 due to a substantial decline in the growth index, valuation index and total return index. EBIT declined 34.78% from $32.49M to $21.19M, earnings per share declined from $0.51 to $0.35, and total revenue declined 12.86% from $182.66M to $159.17M.
C
Hold
1/5/2023Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 1/5/2023 due to a decline in the total return index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 1/5/2023 due to a decline in the total return index.
C
Hold
12/6/2022Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 12/6/2022 due to an increase in the valuation index and volatility index.
Repligen Corporation (RGEN) was upgraded to C+ from C on 12/6/2022 due to an increase in the valuation index and volatility index.
C
Hold
11/21/2022Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 11/21/2022 due to a decline in the valuation index and total return index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 11/21/2022 due to a decline in the valuation index and total return index.
C
Hold
11/3/2022Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 11/3/2022 due to an increase in the valuation index and efficiency index. Total capital increased 1.42% from $2.22B to $2.25B.
Repligen Corporation (RGEN) was upgraded to C+ from C on 11/3/2022 due to an increase in the valuation index and efficiency index. Total capital increased 1.42% from $2.22B to $2.25B.
C
Hold
10/19/2022Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 10/19/2022 due to a decline in the valuation index and total return index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 10/19/2022 due to a decline in the valuation index and total return index.
C
Hold
10/4/2022Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 10/4/2022 due to an increase in the efficiency index, valuation index and volatility index. Net income increased 6.17% from $46.96M to $49.86M, and total capital increased 2.87% from $2.16B to $2.22B.
Repligen Corporation (RGEN) was upgraded to C+ from C on 10/4/2022 due to an increase in the efficiency index, valuation index and volatility index. Net income increased 6.17% from $46.96M to $49.86M, and total capital increased 2.87% from $2.16B to $2.22B.
C
Hold
7/25/2022Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 7/25/2022 due to a decline in the valuation index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 7/25/2022 due to a decline in the valuation index.
C
Hold
7/6/2022Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 7/6/2022 due to an increase in the valuation index, growth index and efficiency index. Net income increased 61.33% from $29.11M to $46.96M, earnings per share increased from $0.5019 to $0.8051, and EBIT increased 12.79% from $51.06M to $57.59M.
Repligen Corporation (RGEN) was upgraded to C+ from C on 7/6/2022 due to an increase in the valuation index, growth index and efficiency index. Net income increased 61.33% from $29.11M to $46.96M, earnings per share increased from $0.5019 to $0.8051, and EBIT increased 12.79% from $51.06M to $57.59M.
C
Hold
3/29/2022Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 3/29/2022 due to a large decline in the volatility index, total return index and solvency index. The quick ratio declined from 2.13 to 1.92.
Repligen Corporation (RGEN) was downgraded to C from C+ on 3/29/2022 due to a large decline in the volatility index, total return index and solvency index. The quick ratio declined from 2.13 to 1.92.
C
Hold
1/7/2022Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 1/7/2022 due to a large decline in the total return index and volatility index.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 1/7/2022 due to a large decline in the total return index and volatility index.
B
Buy
12/21/2021Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 12/21/2021 due to an increase in the total return index and valuation index.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 12/21/2021 due to an increase in the total return index and valuation index.
C
Hold
12/6/2021Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B on 12/6/2021 due to a significant decline in the total return index.
Repligen Corporation (RGEN) was downgraded to C+ from B on 12/6/2021 due to a significant decline in the total return index.
B
Buy
12/3/2021Upgraded
Repligen Corporation (RGEN) was upgraded to B from B- on 12/3/2021 due to a noticeable increase in the total return index and volatility index.
Repligen Corporation (RGEN) was upgraded to B from B- on 12/3/2021 due to a noticeable increase in the total return index and volatility index.
B
Buy
11/18/2021Downgrade
Repligen Corporation (RGEN) was downgraded to B- from B on 11/18/2021 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 40.29% from $37.65M to $22.48M, the quick ratio declined from 2.52 to 2.13, and earnings per share declined from $0.64 to $0.58.
Repligen Corporation (RGEN) was downgraded to B- from B on 11/18/2021 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 40.29% from $37.65M to $22.48M, the quick ratio declined from 2.52 to 2.13, and earnings per share declined from $0.64 to $0.58.
B
Buy
8/20/2021Upgraded
Repligen Corporation (RGEN) was upgraded to B from B- on 8/20/2021 due to a substantial increase in the total return index.
Repligen Corporation (RGEN) was upgraded to B from B- on 8/20/2021 due to a substantial increase in the total return index.
B
Buy
8/12/2021Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 8/12/2021 due to an increase in the growth index and efficiency index. Operating cash flow increased 306.51% from $9.26M to $37.65M, EBIT increased 24.39% from $38.78M to $48.24M, and earnings per share increased from $0.52 to $0.64.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 8/12/2021 due to an increase in the growth index and efficiency index. Operating cash flow increased 306.51% from $9.26M to $37.65M, EBIT increased 24.39% from $38.78M to $48.24M, and earnings per share increased from $0.52 to $0.64.
C
Hold
5/10/2021Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 5/10/2021 due to a noticeable decline in the total return index, volatility index and solvency index.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 5/10/2021 due to a noticeable decline in the total return index, volatility index and solvency index.
B
Buy
3/31/2021Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 3/31/2021 due to a noticeable increase in the total return index and valuation index.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 3/31/2021 due to a noticeable increase in the total return index and valuation index.
C
Hold
3/12/2021Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B on 3/12/2021 due to a significant decline in the total return index and volatility index.
Repligen Corporation (RGEN) was downgraded to C+ from B on 3/12/2021 due to a significant decline in the total return index and volatility index.
B
Buy
3/2/2021Upgraded
Repligen Corporation (RGEN) was upgraded to B from B- on 3/2/2021 due to a noticeable increase in the volatility index, total return index and valuation index.
Repligen Corporation (RGEN) was upgraded to B from B- on 3/2/2021 due to a noticeable increase in the volatility index, total return index and valuation index.
B
Buy
10/28/2020Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 10/28/2020 due to a noticeable increase in the total return index and volatility index.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 10/28/2020 due to a noticeable increase in the total return index and volatility index.
C
Hold
10/13/2020Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 10/13/2020 due to a decline in the total return index.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 10/13/2020 due to a decline in the total return index.
B
Buy
9/24/2020Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 9/24/2020 due to an increase in the total return index and volatility index.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 9/24/2020 due to an increase in the total return index and volatility index.
C
Hold
9/8/2020Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 9/8/2020 due to a noticeable decline in the total return index and efficiency index.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 9/8/2020 due to a noticeable decline in the total return index and efficiency index.
B
Buy
7/31/2020Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 7/31/2020 due to an increase in the growth index, efficiency index and total return index. Operating cash flow increased 75.6% from $9.53M to $16.74M, earnings per share increased from $0.18 to $0.3, and EBIT increased 64.09% from $11.91M to $19.54M.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 7/31/2020 due to an increase in the growth index, efficiency index and total return index. Operating cash flow increased 75.6% from $9.53M to $16.74M, earnings per share increased from $0.18 to $0.3, and EBIT increased 64.09% from $11.91M to $19.54M.
C
Hold
5/8/2020Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 5/8/2020 due to a decline in the growth index and valuation index. Operating cash flow declined 46.08% from $17.67M to $9.53M.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 5/8/2020 due to a decline in the growth index and valuation index. Operating cash flow declined 46.08% from $17.67M to $9.53M.
B
Buy
4/8/2020Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 4/8/2020 due to an increase in the total return index.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 4/8/2020 due to an increase in the total return index.
C
Hold
3/16/2020Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 3/16/2020 due to a decline in the total return index and volatility index.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 3/16/2020 due to a decline in the total return index and volatility index.
B
Buy
2/28/2020Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C on 2/28/2020 due to a large increase in the total return index, growth index and valuation index. Earnings per share increased from $0.03 to $0.0692, and total revenue increased 0.04% from $69.45M to $69.47M.
Repligen Corporation (RGEN) was upgraded to B- from C on 2/28/2020 due to a large increase in the total return index, growth index and valuation index. Earnings per share increased from $0.03 to $0.0692, and total revenue increased 0.04% from $69.45M to $69.47M.
C
Hold
2/25/2020Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 2/25/2020 due to a decline in the total return index and volatility index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 2/25/2020 due to a decline in the total return index and volatility index.
C
Hold
2/7/2020Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 2/7/2020 due to a noticeable increase in the total return index.
Repligen Corporation (RGEN) was upgraded to C+ from C on 2/7/2020 due to a noticeable increase in the total return index.
C
Hold
11/13/2019Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 11/13/2019 due to a noticeable decline in the total return index and valuation index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 11/13/2019 due to a noticeable decline in the total return index and valuation index.
C
Hold
11/5/2019Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 11/5/2019 due to a noticeable decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.17 to $0.03, net income declined 79.51% from $8.1M to $1.66M, and EBIT declined 49.35% from $15.72M to $7.96M.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 11/5/2019 due to a noticeable decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.17 to $0.03, net income declined 79.51% from $8.1M to $1.66M, and EBIT declined 49.35% from $15.72M to $7.96M.
B
Buy
6/12/2019Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 6/12/2019 due to a large increase in the growth index, total return index and efficiency index. Operating cash flow increased 76.2% from $5.56M to $9.79M, EBIT increased 48.62% from $7.85M to $11.67M, and net income increased 42.83% from $5.64M to $8.05M.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 6/12/2019 due to a large increase in the growth index, total return index and efficiency index. Operating cash flow increased 76.2% from $5.56M to $9.79M, EBIT increased 48.62% from $7.85M to $11.67M, and net income increased 42.83% from $5.64M to $8.05M.
C
Hold
5/1/2019Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 5/1/2019 due to an increase in the total return index.
Repligen Corporation (RGEN) was upgraded to C+ from C on 5/1/2019 due to an increase in the total return index.
C
Hold
3/5/2019Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 3/5/2019 due to a noticeable decline in the growth index, total return index and efficiency index. Operating cash flow declined 71.77% from $19.68M to $5.56M.
Repligen Corporation (RGEN) was downgraded to C from C+ on 3/5/2019 due to a noticeable decline in the growth index, total return index and efficiency index. Operating cash flow declined 71.77% from $19.68M to $5.56M.
C
Hold
2/28/2019Downgrade
Repligen Corporation (RGEN) was downgraded to C+ from B- on 2/28/2019 due to a large decline in the total return index, valuation index and efficiency index.
Repligen Corporation (RGEN) was downgraded to C+ from B- on 2/28/2019 due to a large decline in the total return index, valuation index and efficiency index.
B
Buy
10/22/2018Upgraded
Repligen Corporation (RGEN) was upgraded to B- from C+ on 10/22/2018 due to a major increase in the total return index, volatility index and valuation index.
Repligen Corporation (RGEN) was upgraded to B- from C+ on 10/22/2018 due to a major increase in the total return index, volatility index and valuation index.
C
Hold
9/25/2018Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 9/25/2018 due to an increase in the volatility index, total return index and solvency index.
Repligen Corporation (RGEN) was upgraded to C+ from C on 9/25/2018 due to an increase in the volatility index, total return index and solvency index.
C
Hold
8/14/2018Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 8/14/2018 due to a major decline in the valuation index, growth index and efficiency index. EBIT declined 35.56% from $6.63M to $4.27M, earnings per share declined from $0.079 to $0.06, and net income declined 20.59% from $3.45M to $2.74M.
Repligen Corporation (RGEN) was downgraded to C from C+ on 8/14/2018 due to a major decline in the valuation index, growth index and efficiency index. EBIT declined 35.56% from $6.63M to $4.27M, earnings per share declined from $0.079 to $0.06, and net income declined 20.59% from $3.45M to $2.74M.
C
Hold
2/27/2018Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 2/27/2018 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 3,602.71% from -$406 to $14.22M, operating cash flow increased 980.67% from -$1.73M to $15.22M, and net income increased 160.83% from $4.67M to $12.18M.
Repligen Corporation (RGEN) was upgraded to C+ from C on 2/27/2018 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 3,602.71% from -$406 to $14.22M, operating cash flow increased 980.67% from -$1.73M to $15.22M, and net income increased 160.83% from $4.67M to $12.18M.
C
Hold
10/10/2017Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 10/10/2017 due to a major decline in the total return index and volatility index.
Repligen Corporation (RGEN) was downgraded to C from C+ on 10/10/2017 due to a major decline in the total return index and volatility index.
C
Hold
9/25/2017Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 9/25/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
Repligen Corporation (RGEN) was upgraded to C+ from C on 9/25/2017 due to a noticeable increase in the total return index, volatility index and valuation index.
C
Hold
2/24/2017Upgraded
Repligen Corporation (RGEN) was upgraded to C from C- on 2/24/2017 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from $0.03 to $0.1394, operating cash flow increased 264.76% from -$1.19M to $1.95M, and total revenue increased 3.74% from $24.68M to $25.6M.
Repligen Corporation (RGEN) was upgraded to C from C- on 2/24/2017 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from $0.03 to $0.1394, operating cash flow increased 264.76% from -$1.19M to $1.95M, and total revenue increased 3.74% from $24.68M to $25.6M.
C
Hold
11/4/2016Downgrade
Repligen Corporation (RGEN) was downgraded to C- from C on 11/4/2016 due to a significant decline in the growth index, solvency index and efficiency index. Operating cash flow declined 111.23% from $10.56M to -$1.19M, earnings per share declined from $0.11 to $0.03, and net income declined 70.17% from $3.87M to $1.16M.
Repligen Corporation (RGEN) was downgraded to C- from C on 11/4/2016 due to a significant decline in the growth index, solvency index and efficiency index. Operating cash flow declined 111.23% from $10.56M to -$1.19M, earnings per share declined from $0.11 to $0.03, and net income declined 70.17% from $3.87M to $1.16M.
C
Hold
5/6/2016Upgraded
Repligen Corporation (RGEN) was upgraded to C from C- on 5/6/2016 due to a major increase in the growth index and total return index. Earnings per share increased from $0.008 to $0.0492, EBIT increased 72.53% from $3.4M to $5.86M, and total revenue increased 16.99% from $21.45M to $25.09M.
Repligen Corporation (RGEN) was upgraded to C from C- on 5/6/2016 due to a major increase in the growth index and total return index. Earnings per share increased from $0.008 to $0.0492, EBIT increased 72.53% from $3.4M to $5.86M, and total revenue increased 16.99% from $21.45M to $25.09M.
C
Hold
4/13/2016Downgrade
Repligen Corporation (RGEN) was downgraded to C- from C on 4/13/2016 due to a decline in the total return index and valuation index.
Repligen Corporation (RGEN) was downgraded to C- from C on 4/13/2016 due to a decline in the total return index and valuation index.
C
Hold
3/29/2016Upgraded
Repligen Corporation (RGEN) was upgraded to C from C- on 3/29/2016 due to an increase in the valuation index and total return index.
Repligen Corporation (RGEN) was upgraded to C from C- on 3/29/2016 due to an increase in the valuation index and total return index.
C
Hold
3/14/2016Downgrade
Repligen Corporation (RGEN) was downgraded to C- from C on 3/14/2016 due to a significant decline in the volatility index, growth index and total return index. Earnings per share declined from $0.0771 to $0.008, operating cash flow declined 49.12% from $6.59M to $3.35M, and EBIT declined 13.36% from $3.92M to $3.4M.
Repligen Corporation (RGEN) was downgraded to C- from C on 3/14/2016 due to a significant decline in the volatility index, growth index and total return index. Earnings per share declined from $0.0771 to $0.008, operating cash flow declined 49.12% from $6.59M to $3.35M, and EBIT declined 13.36% from $3.92M to $3.4M.
C
Hold
11/9/2015Downgrade
Repligen Corporation (RGEN) was downgraded to C from C+ on 11/9/2015 due to a decline in the valuation index, total return index and efficiency index. Net income declined 29.75% from $3.61M to $2.54M.
Repligen Corporation (RGEN) was downgraded to C from C+ on 11/9/2015 due to a decline in the valuation index, total return index and efficiency index. Net income declined 29.75% from $3.61M to $2.54M.
C
Hold
12/3/2014Upgraded
Repligen Corporation (RGEN) was upgraded to C+ from C on 12/3/2014 due to an increase in the volatility index, valuation index and total return index.
Repligen Corporation (RGEN) was upgraded to C+ from C on 12/3/2014 due to an increase in the volatility index, valuation index and total return index.
C
Hold
11/11/2014Downgrade
Repligen Corporation (RGEN) was downgraded to C from B- on 11/11/2014 due to a large decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0877 to $0.04, net income declined 48.11% from $2.83M to $1.47M, and EBIT declined 9.66% from $3.44M to $3.11M.
Repligen Corporation (RGEN) was downgraded to C from B- on 11/11/2014 due to a large decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0877 to $0.04, net income declined 48.11% from $2.83M to $1.47M, and EBIT declined 9.66% from $3.44M to $3.11M.
B
Buy
10/15/2014Downgrade
Repligen Corporation (RGEN) was downgraded to B- from B on 10/15/2014 due to a significant decline in the total return index and valuation index.
Repligen Corporation (RGEN) was downgraded to B- from B on 10/15/2014 due to a significant decline in the total return index and valuation index.
B
Buy
8/14/2014Downgrade
Repligen Corporation (RGEN) was downgraded to B from A- on 8/14/2014 due to a substantial decline in the growth index and valuation index. Operating cash flow declined 70.98% from $8M to $2.32M, EBIT declined 36.42% from $5.41M to $3.44M, and earnings per share declined from $0.13 to $0.0877.
Repligen Corporation (RGEN) was downgraded to B from A- on 8/14/2014 due to a substantial decline in the growth index and valuation index. Operating cash flow declined 70.98% from $8M to $2.32M, EBIT declined 36.42% from $5.41M to $3.44M, and earnings per share declined from $0.13 to $0.0877.
A
Buy
8/1/2014Upgraded
Repligen Corporation (RGEN) was upgraded to A- from B+ on 8/1/2014 due to a large increase in the total return index.
Repligen Corporation (RGEN) was upgraded to A- from B+ on 8/1/2014 due to a large increase in the total return index.
B
Buy
6/30/2014Downgrade
Repligen Corporation (RGEN) was downgraded to B+ from A- on 6/30/2014 due to a noticeable decline in the total return index, valuation index and volatility index.
Repligen Corporation (RGEN) was downgraded to B+ from A- on 6/30/2014 due to a noticeable decline in the total return index, valuation index and volatility index.
A
Buy
5/2/2014Upgraded
Repligen Corporation (RGEN) was upgraded to A- from B+ on 5/2/2014 due to a noticeable increase in the total return index and volatility index.
Repligen Corporation (RGEN) was upgraded to A- from B+ on 5/2/2014 due to a noticeable increase in the total return index and volatility index.
B
Buy
3/17/2014Downgrade
Repligen Corporation (RGEN) was downgraded to B+ from A- on 3/17/2014 due to a large decline in the valuation index, growth index and total return index. Earnings per share declined from $0.18 to $0.1006, EBIT declined 35.51% from $8.11M to $5.23M, and total revenue declined 18.27% from $18.82M to $15.38M.
Repligen Corporation (RGEN) was downgraded to B+ from A- on 3/17/2014 due to a large decline in the valuation index, growth index and total return index. Earnings per share declined from $0.18 to $0.1006, EBIT declined 35.51% from $8.11M to $5.23M, and total revenue declined 18.27% from $18.82M to $15.38M.
NASDAQ
03/07/2025 3:00PM Eastern
Quotes delayed
